Wiping up finger paint and tackling juice spills is a routine every parent has down pat. Yet they may find themselves playing hide-and-seek with the invisible things little hands leave behind—like bacteria and viruses. Germs stick to all types of surfaces, and kids spread them to more places than you can imagine.
To track down where germs linger, The Clorox Company and global public health organization NSF International conducted a study in homes of families with young children. Researchers analyzed 100 samples from five commonly-touched surfaces, and found bacteria or viruses on all five of the surfaces tested, from the kitchen to the common area to the bathroom, with the bathroom sink being one of the surfaces with the most germs. In fact, the study results found that four times as many households had bathroom sinks that were germier than kitchen countertops.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7359251-clorox-and-nsf-study-shows-which-surfaces-have-most-germs-in-homes-with-kids
Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer.
The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation.
“My mother didn’t make it and unfortunately right now that’s a common story. But it doesn’t have to be the story permanently,” DeGraw said. “By funding research, the Lustgarten Foundation is going to change the course of this disease. I encourage everyone to get involved in some way – join a walk or make a donation.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213753-lustgarten-foundation-pancreatic-cancer-awareness/
Garmin Approach S1 Golf GPS Watch Review Read it Here: http://bestgolfgpssystemshq.com/golf-gps-reviews/garmin-approach-s1-reveiew/ Don't Buy an Approach S1 w/o reading our review. We
spent hours researching the the Approch S1 so you won't have to. Our
in-depth and unbiased review consists of reading hundreds of consumer
reviews, searching the internet for commonly reported problems, finding
and reading user manuals and scouring the internet for hard to find
information you won't find in any other review. For
instance in researching the Garmin Approach S1 watch we found 2 common
complaints among consumers. We then dug deeper on those two issues and
found that there are also a couple of consumer tips that will most
likely resolve both issues. Making them moot points. Checkout
our Garmin Approach S1 golf GPS watch review at the link above to
discover the two biggest complaints about the S1 plus read about all of
the features, pros and cons. http://youtu.be/sFYtTayYhMY
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Nearly four out of five small business owners admit that they have not taken full advantage of national and community resources dedicated to helping small businesses develop and grow, according to a survey recently conducted by Fifth Third Bank.
In advance of Small Business Week May 1-7, Fifth Third Bank (NASDAQ: FITB) conducted a national survey of more than 500 small business owners to assess the landscape – and diagnose common pain points – of U.S. small business owners. According to the results, 81 percent of survey participants said they haven’t worked with local small business resources (e.g., chamber of commerce, SCORE, etc.). Forty-one percent were unsure if the United States Small Business Administration (SBA) had resources to help them. Roughly 38 percent of small business owners say they need help growing revenue and increasing profits.
To view the multimedia release go to:
http://www.multivu.com/players/English/7723852-fifth-third-bank-small-business/
Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children’s Hospital of Philadelphia (CHOP) co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/chop/48124/
https://exodraft-heatrecovery.com/heat-recovery-in-industry/
https://exodraft-heatrecovery.com/
With 7 production facilities located in both Denmark and Sweden, DOT is the leading Nordic full-service supplier of metal surface treatment.Today, we are visiting DOT in Køge, Denmark, where they specialize in hot-dip galvanization.
On top of the savings and operative benefits, DOT has the ability, using exodraft’s Trendlog system, to assess remotely, via a computer, the efficiency of their heat recovery system as well as monitor, in real time, its generated energy savings.
Heat recovery is simply good common sense and benefits both the economy, operations as well as the environment.
Visit http://exodraft-heatrecovery.com to learn more about how to recover your waste heat and contact us today for a free assessment.
Currently melanoma is the deadliest form of skin cancer and one of the most common cancers in women under 40 years old in the United States. The first line of defense in helping to reduce the risk of developing melanoma is by wearing broad spectrum UVA and UVB SPF protection. L’Oréal Paris, a leading global beauty brand, and Melanoma Research Alliance (MRA), the leading private funder of melanoma research, announced today the launch of It’s THAT Worth It To Me. This social media campaign encourages women to donate 15 social media seconds by sharing why SPF protection or using sunless tanner is worth it to protect their skin, their beauty and their life. For every social share, L’Oréal Paris will donate $1 to MRA to fund the L’Oréal Paris - MRA Team Science Award Research Grant, up to $250,000 in 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7459051-l-oreal-paris-mra-it-s-that-worth-it/
Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer.
Over the last 30 years, more people were diagnosed with skin cancer worldwide than all other cancers combined, making it the most common type of cancer1. This represents a challenge for health care providers in the years to come. With a cure rate of more than 95 percent2, electronic brachytherapy offers a refined treatment modality with excellent cosmesis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62823-elekta-nucletron-esteya-electronic-brachytherapy-treating-skin-cancer
What do vampire, romance lit and the Bible have in common...Plenty. Escaping the Vampire offers your teen girl a real immortal hero who can truly fulfill her heart’s deepest desire, Christ. Escaping the Vampire Kimberly Powers Book Trailer
Find out more about this book and author here http://tinyurl.com/EscapingtheVampirePowers Religion Christian Life Social Issues
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
